Literature DB >> 10852641

Pharmacological prophylaxis of post-traumatic epilepsy.

A Iudice1, L Murri.   

Abstract

Early and late epileptic seizures are a frequent complication of severe head traumas. The administration of anticonvulsant drugs immediately after head injury is commonly implemented as a prophylactic measure; however, there is a lack of consensus on the usefulness of prophylaxis with anticonvulsants for the prevention of late post-traumatic epilepsy (PTE). The inconsistent evidence accumulated so far from clinical studies, most nonrandomised and uncontrolled in design, and the limited knowledge of the processes underlying post-traumatic epileptogenesis, do not warrant empirical pharmacological prophylaxis with long term administration of conventional anticonvulsants. Phenytoin and phenobarbital (phenobarbitone) are used to a large extent in this indication. As a general rule, a benefit/risk analysis in individual patients should drive prophylactic drug prescription in PTE as it can have potential detrimental effects on a patient's recovery. New compounds, such as free-radical scavengers and antiperoxidants, show encouraging experimental results, but their clinical use is still very limited.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852641     DOI: 10.2165/00003495-200059050-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  109 in total

1.  [Post-traumatic seizure prevention--results of a survey of 127 neurosurgery clinics].

Authors:  W A Dauch; M Schütze; M Güttinger; B L Bauer
Journal:  Zentralbl Neurochir       Date:  1996

Review 2.  Preventing post-traumatic epilepsy after brain injury: weighing the costs and benefits of anticonvulsant prophylaxis.

Authors:  T D Hernandez
Journal:  Trends Pharmacol Sci       Date:  1997-02       Impact factor: 14.819

3.  Relation of prophylactic medication to the occurrence of early seizures following craniocerebral trauma.

Authors:  B L Rish; W F Caveness
Journal:  J Neurosurg       Date:  1973-02       Impact factor: 5.115

4.  [Clinical attempt to prevent post-traumatic epilepsy following severe brain injuries in adults].

Authors:  K Popek; F Musil
Journal:  Cas Lek Cesk       Date:  1969-01

Review 5.  Cerestat and other NMDA antagonists in ischemic stroke.

Authors:  K R Lees
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

6.  Prophylaxis with diphenylhydantoin and phenobarbital and alumina-gel monkey model. I. Twelve months of treatment: seizure, EEG, blood, and behavioral data.

Authors:  J S Lockard; W C Congdon; L L DuCharme; B J Huntsman
Journal:  Epilepsia       Date:  1976-03       Impact factor: 5.864

7.  Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial.

Authors:  J P Muizelaar; A Marmarou; H F Young; S C Choi; A Wolf; R L Schneider; H A Kontos
Journal:  J Neurosurg       Date:  1993-03       Impact factor: 5.115

8.  Decreased plasma protein binding of valproate in patients with acute head trauma.

Authors:  G D Anderson; B E Gidal; R J Hendryx; A B Awan; N R Temkin; A J Wilensky; H R Winn
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

9.  Prophylactic treatment of posttraumatic epilepsy: results of a long-term follow-up in Czechoslovakia.

Authors:  Z Servít; F Musil
Journal:  Epilepsia       Date:  1981-06       Impact factor: 5.864

10.  [Prevention of late post-traumatic epilepsy by phenytoin in severe brain injuries. 2 years' follow-up].

Authors:  J C Pechadre; M Lauxerois; G Colnet; C Commun; C Dimicoli; M Bonnard; J Gibert; J Chabannes
Journal:  Presse Med       Date:  1991-05-11       Impact factor: 1.228

View more
  13 in total

1.  Late Post-traumatic Epilepsy in Children and Young Adults: Impropriety of Long-Term Antiepileptic Prophylaxis and Risks in Tapering.

Authors:  Sandra Strazzer; Marco Pozzi; Paolo Avantaggiato; Nicoletta Zanotta; Roberta Epifanio; Elena Beretta; Francesca Formica; Federica Locatelli; Sara Galbiati; Emilio Clementi; Claudio Zucca
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

Review 2.  Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.

Authors:  James H Fischer; Tejal V Patel; Patricia A Fischer
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Risk Factors and Phenytoin Prophylaxis for Early Post-Traumatic Seizures among Patients with Traumatic Brain Injury.

Authors:  Kin Hup Chan; John Tharakan; Hillol Kanti Pal; Naeem Khan; Yew Chin Tan
Journal:  Malays J Med Sci       Date:  2010-10

4.  Posttraumatic seizures in survivors of torture: manifestations, diagnosis, and treatment.

Authors:  Alejandro Moreno; Michael Peel
Journal:  J Immigr Health       Date:  2004-10

5.  Traumatic brain injury induces rapid enhancement of cortical excitability in juvenile rats.

Authors:  Joshua Nichols; Roxy Perez; Chen Wu; P David Adelson; Trent Anderson
Journal:  CNS Neurosci Ther       Date:  2014-12-05       Impact factor: 5.243

6.  Magnetization transfer MR imaging in patients with posttraumatic epilepsy.

Authors:  Rajesh Kumar; Rakesh K Gupta; Mazhar Husain; Davender K Vatsal; Sanjeev Chawla; Ram Kishore S Rathore; Sunil Pradhan
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

7.  Aquaporin-4 Reduces Post-Traumatic Seizure Susceptibility by Promoting Astrocytic Glial Scar Formation in Mice.

Authors:  Daniel C Lu; Zsolt Zador; Jinghua Yao; Farbod Fazlollahi; Geoffrey T Manley
Journal:  J Neurotrauma       Date:  2021-04-15       Impact factor: 5.269

8.  Randomized Controlled Trial of Prophylactic Phenytoin After Neurosurgery for Brain Tumor.

Authors:  Patricia E. Penovich
Journal:  Epilepsy Curr       Date:  2002-07       Impact factor: 7.872

9.  Antiepileptic Drugs Elevate Astrocytic Kir4.1 Expression in the Rat Limbic Region.

Authors:  Takahiro Mukai; Masato Kinboshi; Yuki Nagao; Saki Shimizu; Asuka Ono; Yoshihisa Sakagami; Aoi Okuda; Megumi Fujimoto; Hidefumi Ito; Akio Ikeda; Yukihiro Ohno
Journal:  Front Pharmacol       Date:  2018-08-06       Impact factor: 5.810

Review 10.  The promise of new antiepileptic drugs.

Authors:  John S Duncan
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.